SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Trinity Biotech (TRIBY)
TRIB 0.755-0.4%3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Kevin Ameling who wrote (7325)11/1/1997 4:07:00 PM
From: Ron Luhmann   of 14328
 
this post from the Triby AOL board ... Polly visited Dublin Oct 12-13th

Subject: Re: Earnings
Date: Sat, Nov 1, 1997 11:20 EST
From: PollyBust
Message-id:

Yes, The HIV test is important, but what your overlooking is the huge potential of their uni-gold platform. Most of the tests that they now have (nearly 100) as well as others, can be adapted to this format, which means inexpensive rapid tests w/ good profit margins. This is where the potential of this company is down the road. They are also looking into puting several tests on the same card, so when a person goes in to get a test for say Hepatitis,
he/she can be tested for HIV, herpes, and god knows what else. The # dropped by Trinity when we were there last month was 5 tests at once, so this could be big and give them an advantage over competition. Yes, we all would like to see HIV test come to the US market, but it will not make or break co, long term. It's more important for braking the ice at the FDA for other tests, IMHO.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext